{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:34:14Z","timestamp":1791185654057,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ijpharm.2012.04.053","type":"journal-article","created":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T20:21:12Z","timestamp":1335644472000},"page":"11-22","source":"Crossref","is-referenced-by-count":23,"title":["Impact of the experimental conditions on drug release from parenteral depot systems: From negligible to significant"],"prefix":"10.1016","volume":"432","author":[{"given":"C.","family":"Delplace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kreye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dan\u00e8de","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Siepmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Siepmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.04.053_bib0005","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1023\/A:1016482809810","article-title":"A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres","volume":"19","author":"Aubert-Pouessel","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0168-3659(99)00250-3","article-title":"Development of microspheres for neurological disorders: from basics to clinical applications","volume":"65","author":"Benoit","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1018822002353","article-title":"pH and osmotic pressure inside biodegradable microspheres during erosion","volume":"16","author":"Brunner","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0020","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1023\/A:1020730102176","article-title":"Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP","volume":"19","author":"Burgess","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejps.2004.03.001","article-title":"Assuring quality and performance of sustained and controlled release parenterals","volume":"21","author":"Burgess","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0030","series-title":"The Mathematics of Diffusion","author":"Crank","year":"1975"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1208\/pt060242","article-title":"Development of a dialysis in vitro release method for biodegradable microspheres","volume":"6","author":"D'Souza","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2011.02.066","article-title":"Development of mass transport resistance in poly(lactide-co-glycolide) films and particles \u2013 a mechanistic study","volume":"409","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems \u2013 a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2010.11.020","article-title":"Pore formation and pore closure in poly(d,l-lactide-co-glycolide) films","volume":"150","author":"Fredenberg","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2005.12.051","article-title":"Programmable implants \u2013 from pulsatile to controlled release","volume":"314","author":"Guse","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2005.12.050","article-title":"Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids","volume":"314","author":"Guse","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0065","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0142-9612(01)00291-5","article-title":"Dexamethasone\/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices","volume":"23","author":"Hickey","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1773-2247(11)50067-X","article-title":"Tamoxifen citrate loaded biodegradable poly(sebacic acid-co-ricinoleic acid) microparticles, in vitro characterization","volume":"21","author":"Hiremath","year":"2011","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1021\/mp060041n","article-title":"Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins","volume":"4","author":"Kang","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2007.10.030","article-title":"PLGA-based drug delivery systems: importance of the type of drug and device geometry","volume":"354","author":"Klose","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0085","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11095-008-9747-4","article-title":"Towards more realistic in vitro release measurement techniques for biodegradable microparticles","volume":"26","author":"Klose","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2009.09.012","article-title":"Drug release from PLGA-based microparticles. Effects of the microparticle: bulk fluid ratio","volume":"383","author":"Klose","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2007.02.005","article-title":"Towards controlled release of BDNF \u2013 manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain","volume":"119","author":"Koennings","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2007.02.008","article-title":"Influence of wettability and surface activity on release behavior of hydrophilic substances from lipid matrices","volume":"119","author":"Koennings","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF02830519","article-title":"A novel in vitro release technique for peptide containing biodegradable microspheres","volume":"1","author":"Kostanski","year":"2000","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1208\/pt010427","article-title":"Evaluation of orntide microspheres in a rat animal model and correlation to in vitro release profiles","volume":"1","author":"Kostanski","year":"2000","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2010.10.048","article-title":"Drug release mechanisms of compressed lipid implants","volume":"404","author":"Kreye","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0120","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejpb.2011.02.011","article-title":"Drug release mechanisms of cast lipid implants","volume":"78","author":"Kreye","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejps.2011.03.013","article-title":"Controlled release implants based on cast lipid blends","volume":"43","author":"Kreye","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0130","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1002\/jps.22574","article-title":"Cast lipid implants for controlled drug delivery: importance of the tempering conditions","volume":"100","author":"Kreye","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0135","doi-asserted-by":"crossref","unstructured":"Kreye, F., Hamm, G., Karrout, Y., Legouffe, R., Bonnel, D., Siepmann, F., Siepmann, J. MALDI-TOF MS imaging of controlled release implants, J. Control. Release, http:\/\/dx.doi.org\/10.1016\/j.jconrel.2012.04.017, in press.","DOI":"10.1016\/j.jconrel.2012.04.017"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2004.07.029","article-title":"Mapping neutral microclimate pH in PLGA microspheres","volume":"101","author":"Li","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2008.04.004","article-title":"In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting","volume":"129","author":"Martinez","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.09.028","article-title":"Breakout session summary from AAPS\/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products","volume":"142","author":"Martinez","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/cncr.11922","article-title":"Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma","volume":"100","author":"Menei","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/17425247.2.2.363","article-title":"Drug delivery into the brain using poly(lactide-co-glycolide) microspheres","volume":"2","author":"Menei","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2004.02.027","article-title":"Continuous release of rh-interferon \u03b1-2a from triglyceride matrices","volume":"97","author":"Mohl","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2011.08.035","article-title":"Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal\u00ae Consta\u00ae","volume":"420","author":"Rawat","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2008.11.026","article-title":"Lipid extrudates as novel sustained release systems for pharmaceutical proteins","volume":"134","author":"Schulze","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/ps010307","article-title":"A short term (accelerated release) approach to evaluate peptide release from PLGA depot-formulations","volume":"1","author":"Shameem","year":"1999","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2011.10.020","article-title":"Accelerated in vitro release testing of implantable PLGA microsphere\/PVA hydrogel composite coatings","volume":"422","author":"Shen","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0169-409X(01)00116-8","article-title":"Mathematical modeling of bioerodible polymeric drug delivery systems","volume":"48","author":"Siepmann","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2005.07.027","article-title":"Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms","volume":"314","author":"Siepmann","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0200","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2008.09.004","article-title":"Mathematical modeling of drug delivery","volume":"364","author":"Siepmann","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2008.03.009","article-title":"A novel mathematical model quantifying drug release from lipid implants","volume":"128","author":"Siepmann","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijpharm.2011.07.015","article-title":"Mathematical modeling of drug release from lipid dosage forms","volume":"418","author":"Siepmann","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0215","doi-asserted-by":"crossref","unstructured":"Siepmann, J., Siepmann, F. Modeling of diffusion controlled drug delivery. J. Control. Release, http:\/\/dx.doi.org\/10.1016\/j.jconrel.2011.10.006, in press.","DOI":"10.1016\/j.jconrel.2011.10.006"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0220","series-title":"Controlled Drug Release of Oral Dosage Forms","author":"Vergnaud","year":"1993"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1773-2247(11)50062-0","article-title":"Controlled drug release from contact lenses: a comprehensive review from 1965\u2013present","volume":"21","author":"White","year":"2011","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0230","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0168-3659(01)00403-5","article-title":"Preparation, characterization and in vivo evaluation of 120-day poly(d,l-lactide) leuprolide microspheres","volume":"75","author":"Woo","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2006.02.015","article-title":"Elevated temperature accelerated release testing of PLGA microspheres","volume":"112","author":"Zolnik","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0240","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jconrel.2007.05.034","article-title":"Effect of acidic pH on PLGA microsphere degradation and release","volume":"122","author":"Zolnik","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.04.053_bib0245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2008.01.004","article-title":"Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres","volume":"127","author":"Zolnik","year":"2008","journal-title":"J. Control. Release"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312003997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312003997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T21:37:43Z","timestamp":1551908263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312003997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":49,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0378517312003997"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.04.053","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}